20.500.12556/ReVIS-10024 UPORABA PSIHADELIKOV V PSIHOTERAPIJI The use of psychedelics in psychotherapy Teoretična izhodišča: V naši družbi se vsako leto srečujemo z vse večjim številom duševnih bolezni, razvoj novih psihiatričnih zdravil pa upada. Inovacijo v zdravstvenem svetu predstavlja uporaba psihadelikov v psihoterapiji. Gre za strokovno nadzorovano uporabo substanc, kot so ketamin, MDMA, psilocibin, LSD in drugih psihadelikov, ki v novih študijah obetajo dobre rezultate v boju proti depresiji, tesnobi, posttravmatski stresni motnji in drugim duševnim boleznim. Metoda: Uporabljen je bil kritični pregled literature s pomočjo podatkovnih baz Science Direct, PubMed, Google Scholar, The American Journal of Psychiatry. Zaradi naravnanosti teme bomo uporabili tudi spletno stran Multidisciplinary Association for Psychedelic Studies (MAPS). Omejitveni kriteriji iskanja so bili: brezplačni dostop, celotno besedilo članka, kakovostno izvedena študija in jezik angleščina. Pri pregledu literature je bila uporabljena vsebinska analiza prebranega gradiva. Rezultati: V podrobnejši pregled celotnega besedila je bilo od 329.080 zadetkov vključenih 413 zadetkov, v končno analizo pa 70 člankov. Odkrili smo, da gre za dobro metodološko zasnovane raziskave: hierarhično je najvišje na lestvici 44 sistematičnih pregledov randomiziranih in nerandomiziranih kliničnih študij ter metaanaliz, sledi 17 posamičnih randomiziranih in nerandomiziranih kliničnih študij in 9 sistematičnih pregledov korelacijskih študij. Ugotovitve: Uporaba psihadelikov v psihoterapiji se kaže kot učinkovita nova metoda za zdravljenje raznovrstnih duševnih motenj. Med najbolj raziskane psihadelike sodi ketamin, med najmanj raziskane pa LSD. Raziskave na področju LSD-ja predvsem ugotavljajo njegov potencialni terapevtski potencial pri zdravljenju depresije in odvisnosti od alkohola. MDMA je v ospredju raziskav, ki se ukvarjajo s psihadelično psihoterapijo na področju posttravmatske stresne motnje, pa tudi na področju tesnobe. Ketamin in psilocibin pa stopita v ospredje pri študijah, ki naslavljajo depresijo in samomorilnost. Zagotovo je na področju psihadelikov potrebno še veliko raziskav, a so tudi dosedanji rezultati večine študij obetavni. Prav tako, na koncu še obravnavamo morebitne omejitve in potenciale za nadaljnje raziskave. Theoretical Background: Every year, our society faces an increasing number of mental illnesses, and the development of new psychiatric drugs is declining. The use of psychedelics in psychotherapy is an innovation in the medical world. This is the professionally supervised controlled use of substances such as ketamine, MDMA, psilocybin, LSD and other psychedelics which, in new studies, promise good results in the fight against depression, anxiety, post- traumatic stress disorder and other mental illnesses. Methods: A critical literature review using Science Direct, PubMed, Google Scholar, The American Journal of Psychiatry databases was used. The limiting search criteria were: free access, full text of the article, quality of the study, and English language. A content analysis of the material read was used for the literature review. Results: A critical literature review using Science Direct, PubMed, Google Scholar, The American Journal of Psychiatry databases was used. The Multidisciplinary Association for Psychedelic Studies (MAPS) website will also be used due to the focus of the topic. The limiting search criteria were: free access, full text of the article, quality of the study, and English language. A content analysis of the material read was used for the literature review. Findings: The use of psychedelics in psychotherapy is proving to be an effective new method for treating a wide range of mental disorders. Ketamine is one of the most researched psychedelics and LSD one of the least researched. Research on LSD has mainly identified its potential therapeutic potential in the treatment of depression and alcohol addiction. MDMA is at the forefront of research dealing with psychedelic psychotherapy in the area of post-traumatic stress disorder, as well as in the area of anxiety. Ketamine and psilocybin have come to the front in studies addressing depression and suicidality. There is certainly a lot of research to be done in the field of psychedelics, but the results of most of the studies so far are also promising. We also end by discussing possible limitations and potentials for further research. psihadeliki v psihoterapiji pregled literature duševno zdravje depresija tesnoba posttravmatska stresna motnja psihadeliki v psihoterapiji pregled literature duševno zdravje depresija tesnoba posttravmatska stresna motnja true false false Slovenski jezik Angleški jezik Diplomsko delo/naloga 2023-10-21 19:25:13 2023-10-21 19:25:16 2024-06-12 20:49:18 0000-00-00 00:00:00 2023 0 0 0000-00-00 NiDoloceno NiDoloceno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 1970-01-01 24934 4786$$Diploma_KuznikMasa_2023_09_15(2).pdf 4786$$Diploma_KuznikMasa_2023_09_15(2).pdf 1 88A855963C7ED0F6EAF8339CEA0F8440 ea7ea1c1215c1f9bd9ec42a2f3cd16e45f6b13ca0fdd2b06e62f315c54f91ad0 824f9ba7-2899-11ef-9c9e-001a4af901a5 https://revis.openscience.si/Dokument.php?lang=slv&id=11287 Fakulteta za uporabne družbene študije 0 0 0